Thyroid	thyroid	O	O
function	function	O	O
and	and	O	O
urine-concentrating	urine-concentrating	O	O
ability	ability	O	O
during	during	O	O
lithium	lithium	S_chemicals	O
treatment	treatment	O	O
.	.	O	O

It	it	O	O
has	has	O	O
been	been	O	O
suggested	suggested	O	O
that	that	O	O
adenylate	adenylate	B_chemicals	O
cyclase	cyclase	S_chemicals	O
inhibition	inhibition	O	O
may	may	O	O
be	be	O	O
important	important	O	O
in	in	O	O
the	the	O	O
development	development	O	O
of	of	O	O
both	both	O	O
nephrogenic	nephrogenic	O	B_disease
diabetes	diabetes	O	B_disease
insipidus	insipidus	O	I_disease
and	and	O	O
hypothyroidism	hypothyroidism	O	S_disease
during	during	O	O
lithium	lithium	S_chemicals	O
treatment	treatment	O	O
.	.	O	O

We	we	O	O
measured	measured	O	O
serum	serum	O	O
thyroxine	thyroxine	S_chemicals	O
and	and	O	O
urine-concentrating	urine-concentrating	O	O
ability	ability	O	O
(	(	O	O
Umax	umax	O	O
)	)	O	O
in	in	O	O
response	response	O	O
to	to	O	O
desmopressin	desmopressin	S_chemicals	O
(	(	O	O
DDAVP	ddavp	S_chemicals	O
)	)	O	O
in	in	O	O
85	85	O	O
patients	patients	O	O
receiving	receiving	O	O
lithium	lithium	S_chemicals	O
.	.	O	O

Hypothyroidism	hypothyroidism	O	S_disease
developed	developed	O	O
in	in	O	O
eight	eight	O	O
patients	patients	O	O
while	while	O	O
they	they	O	O
were	were	O	O
taking	taking	O	O
lithium	lithium	S_chemicals	O
.	.	O	O

Impaired	impaired	O	O
Umax	umax	O	O
was	was	O	O
found	found	O	O
in	in	O	O
both	both	O	O
euthyroid	euthyroid	O	O
and	and	O	O
hypothyroid	hypothyroid	O	O
patients	patients	O	O
while	while	O	O
some	some	O	O
hypothyroid	hypothyroid	O	O
patients	patients	O	O
concentrated	concentrated	O	O
their	their	O	O
urine	urine	O	O
well	well	O	O
.	.	O	O

It	it	O	O
is	is	O	O
concluded	concluded	O	O
that	that	O	O
the	the	O	O
dominant	dominant	O	O
mechanisms	mechanisms	O	O
by	by	O	O
which	which	O	O
lithium	lithium	S_chemicals	O
exerts	exerts	O	O
these	these	O	O
two	two	O	O
effects	effects	O	O
are	are	O	O
different	different	O	O
.	.	O	O

